{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:37:06Z","timestamp":1791581826073,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30-EY026877"],"award-info":[{"award-number":["P30-EY026877"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.xops.2023.100298","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T16:49:16Z","timestamp":1678553356000},"page":"100298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-7360","authenticated-orcid":false,"given":"Jeffrey L.","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2025-545X","authenticated-orcid":false,"given":"Gala","family":"Beykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie R.","family":"Satterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron L.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Albini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2023.100298_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100298_bib2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ophtha.2011.11.003","article-title":"Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement","volume":"119","author":"Chang","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2023.100298_bib3","series-title":"Adler's Physiology of the Eye","first-page":"550","article-title":"The optic nerve","author":"Goldberg","year":"2011"},{"key":"10.1016\/j.xops.2023.100298_bib4","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1167\/iovs.14-14643","article-title":"Rates of glaucomatous visual field change in a large clinical population","volume":"55","author":"Chauhan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100298_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1755-3768.2012.02492.x","article-title":"Rates of visual field progression in clinical glaucoma care","volume":"91","author":"Heijl","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.xops.2023.100298_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1167\/iovs.13-13006","article-title":"Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime","volume":"55","author":"Saunders","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100298_bib7","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1111\/aos.12788","article-title":"Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1","volume":"93","author":"Aptel","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.xops.2023.100298_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40123-019-00222-z","article-title":"Open-angle glaucoma: burden of illness, current therapies, and the management of nocturnal IOP variation","volume":"9","author":"Sheybani","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.xops.2023.100298_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17469899.2016.1180246","article-title":"What rates of glaucoma progression are clinically significant?","volume":"11","author":"Saunders","year":"2016","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.xops.2023.100298_bib10","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1167\/iovs.18-25140","article-title":"Rates of visual field loss in primary open-angle glaucoma and primary angle-closure glaucoma: asymmetric patterns","volume":"59","author":"Yousefi","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100298_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/347083a0","article-title":"Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor","volume":"347","author":"Faktorovich","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.xops.2023.100298_bib12","doi-asserted-by":"crossref","first-page":"11249","DOI":"10.1073\/pnas.89.23.11249","article-title":"Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light","volume":"89","author":"LaVail","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.xops.2023.100298_bib13","first-page":"592","article-title":"Protection of mouse photoreceptors by survival factors in retinal degenerations","volume":"39","author":"LaVail","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100298_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/hum.1997.8.4-423","article-title":"Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse","volume":"8","author":"Cayouette","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.xops.2023.100298_bib15","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1523\/JNEUROSCI.18-22-09282.1998","article-title":"Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse","volume":"18","author":"Cayouette","year":"1998","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.xops.2023.100298_bib16","first-page":"3292","article-title":"Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa","volume":"43","author":"Tao","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100298_bib17","doi-asserted-by":"crossref","first-page":"e9495","DOI":"10.1371\/journal.pone.0009495","article-title":"CNTF induces regeneration of cone outer segments in a rat model of retinal degeneration","volume":"5","author":"Li","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2023.100298_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1006\/exer.2002.1176","article-title":"Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds\/peripherin mutation","volume":"74","author":"Bok","year":"2002","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2023.100298_bib19","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1018987108","article-title":"Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.xops.2023.100298_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajo.2013.03.021","article-title":"Ciliary Neurotrophic Factor Retinitis Pigmentosa Study Groups. Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa","volume":"156","author":"Birch","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100298_bib21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00002826-199512000-00003","volume":"18","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.xops.2023.100298_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J"},{"key":"10.1016\/j.xops.2023.100298_bib23","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1167\/iovs.12-9970","article-title":"Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases","volume":"53","author":"Kauper","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100298_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2018.09.041","article-title":"Effect of ciliary neurotrophic factor on retinal neurodegeneration in patients with macular telangiectasia type 2: a randomized clinical trial","volume":"126","author":"Chew","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2023.100298_bib25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ajo.2014.12.013","article-title":"Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial","volume":"159","author":"Chew","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100298_bib26","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.0600236103","article-title":"Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants","volume":"103","author":"Sieving","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.xops.2023.100298_bib27","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1167\/iovs.10-6479","article-title":"Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment","volume":"52","author":"Talcott","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100298_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nn1192","article-title":"FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation","volume":"7","author":"Song","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.xops.2023.100298_bib29","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1167\/iovs.03-1342","article-title":"Encapsulated cell-based intraocular delivery of ciliary neurotrophic factor in normal rabbit: dose-dependent effects on ERG and retinal histology","volume":"45","author":"Bush","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100298_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ajo.2012.07.005","article-title":"Retinal nerve fiber layer atrophy is associated with visual field loss over time in glaucoma suspect and glaucomatous eyes","volume":"155","author":"Sehi","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100298_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.0953-816X.2003.03107.x","article-title":"CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway","volume":"19","author":"Ji","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.xops.2023.100298_bib32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.exer.2009.01.007","article-title":"CNTF induces photoreceptor neuroprotection and Muller glial cell proliferation through two different signaling pathways in the adult zebrafish retina","volume":"88","author":"Kassen","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2023.100298_bib33","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1634\/stemcells.2008-0222","volume":"26","author":"Bhattacharya","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.xops.2023.100298_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.mcn.2009.03.002","article-title":"Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF","volume":"41","author":"Muller","year":"2009","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.xops.2023.100298_bib35","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1038\/s41598-018-23220-w","article-title":"Impact of different visual field testing paradigms on sample size requirements for glaucoma clinical trials","volume":"8","author":"Wu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2023.100298_bib36","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1167\/iovs.12-9476","article-title":"Intervals between visual field tests when monitoring the glaucomatous patient: wait-and-see approach","volume":"53","author":"Crabb","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914523000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914523000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:25:25Z","timestamp":1763015125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914523000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2666914523000301"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2023.100298","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2023.100298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100298"}}